The Business Research Company’s report on the Genotyping Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
What are the key drivers behind the genotyping market’s growth in recent years?
The rising prevalence of cancer and genetic disorders is expected to propel the growth of the genotyping market going forward. Cancer refers to a broad collection of illnesses that can begin in practically any organ or tissue of the body, while genetic disorders refer to a condition wholly or partially brought on by a deviation from the usual DNA sequence. Scientists can use genotyping to investigate genetic variances such as single nucleotide variations, copy number variations, and substantial structural changes in DNA. Genetic testing, or genotyping, looks for specific gene mutations (changes) that may raise a person’s risk of acquiring certain cancers. For instance, in February 2024, according to World Health Organization, a Switzerland-based specialized agency focused on international public health, in 2022, approximately 20 million new cancer cases were reported, resulting in 9.7 million deaths. Meanwhile, an estimated 53.5 million individuals were alive five years after receiving a cancer diagnosis. Furthermore, in February 2023, according to Gene People UK, a UK-based registered charity, it is estimated that 1 in every 25 children has a hereditary condition. This implies that 30,000 babies and children are newly diagnosed in the UK annually, and more than 2.4 million children and adults have a genetic disorder. Therefore, the increasing prevalence of cancer and genetic disorders is driving the growth of the genotyping market.
Access Your Free Sample of the Global Genotyping Market Report – Get Insights Now!
Genotyping Market Report 2025
How does the future projection of the genotyping market size compare to its historical growth?
The genotyping market size has grown rapidly in recent years. It will grow from $23.04 billion in 2024 to $26.63 billion in 2025 at a compound annual growth rate (CAGR) of 15.6%. The growth in the historic period can be attributed to government initiatives and funding, rapid decline in genotyping costs, expansion of biobanks and genetic databases, increasing prevalence of genetic disorders, pharmacogenomics and drug development
The genotyping market size is expected to see rapid growth in the next few years. It will grow to $51.43 billion in 2029 at a compound annual growth rate (CAGR) of 17.9%. The growth in the forecast period can be attributed to increased adoption in clinical diagnostics, growing demand for personalized medicine, rise in research and development initiatives, expanding application in agriculture and livestock. Major trends in the forecast period include rise in demand for pharmacogenomics, advancements in next-generation sequencing (ngs), expansion in precision medicine initiatives, growth in direct-to-consumer (dtc) genetic testing, focus on cancer genomics and personalized therapies.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
Genotyping Market Report 2025
Which key players are shaping the future of the genotyping market?
Major companies operating in the genotyping market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Eurofins Scientific SE, Agilent Technologies, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Inotiv, Takara Bio Inc., Integrated DNA Technologies Ltd., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies, Macrogen Inc., Pacific Biosciences of California, Standard BioTools Inc., GENEWIZ, Transnetyx, Agena Bioscience Inc., Genotypic Technology Pvt Ltd., BMG LABTECH GmbH, Bioline, Biofortuna Limited, Xcelris Genomics
What trends will propel the growth and evolution of the genotyping market?
Product innovations are a key trend gaining popularity in the genotyping market. Companies operating in the genotyping market are adopting innovative solutions to sustain their position in the market. For instance, in May 2022, Neogen, a US-based food safety company, and Gencove Inc., a US-based provider of a sequencing platform for genome discovery, launched InfiniSEEK, an innovative and cost-effective solution for whole genome sequencing and targeted SNP (single nucleotide polymorphism) analysis. It is the first whole-genome and genotyping sequencing solution for cattle breeders. With InfiniSEEK, the industry now has a platform to reliably manage more than 400 bovine genetic characteristics and circumstances, discover new variables impacting desirable phenotypes, and decrease selection bias by sequencing more or all a population. With the release of this unique service, consumers now have a data-rich, cost-effective method of profiling cattle worldwide by combining genome-wide sequencing data, specific genetic traits, and parentage markers.
Which regions are expected to become dominant players in the genotyping market?
North America was the largest region in genotyping market in 2024. The regions covered in the genotyping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/genotyping-global-market-report
What are the emerging key segments in the genotyping market, and how are they evolving?
The genotyping market covered in this report is segmented –
1) By Product And Services: Instruments, Reagents And Kits, Bioinformatics, Genotyping Service
2) By Technology: Microarrays, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction, Matrix-Assisted Laser Desorption Or Ionization (Maldi-Tof) Mass Spectrometry, Other Technologies
3) By Application: Pharmacogenomics, Diagnostics And Personalized Medicine, Animal Genetics, Agricultural Biotechnology, Other Applications
4) By End-User: Pharmaceutical And Biopharmaceutical Companies, Diagnostics And Research Laboratories, Academic Institutes, Other End-Users
Subsegments:
1) By Instruments: Sequencers, PCR Machines, Microarrays, Genotyping Platforms
2) By Reagents And Kits: DNA Extraction Kits, PCR Reagents, SNP Genotyping Kits, Next-Generation Sequencing (NGS) Kits
3) By Bioinformatics: Data Analysis Software, Genomic Data Management Tools, Cloud-based Solutions
4) By Genotyping Services: Contract Research Organizations (CRO) Services, Custom Genotyping Services, Sample Preparation Services
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
Genotyping Market Report 2025
What defines the structure and scope of the genotyping market?
Genotyping is a lab procedure examining a person’s germline DNA for nucleotides or bases to see if certain variations are present. Researchers can explore genetic variants such as single nucleotide variations, copy number variations, and substantial structural alterations in DNA using genotyping. It is used in various fields, including agriculture, medicine, and basic science.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
